{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:17:59Z","timestamp":1788020279354,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trsl.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:18:43Z","timestamp":1784855923000},"page":"122-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dynamic 3D imaging system detects vasculogenic mimicry and screens inhibitors in EGFR-mutant lung cancer"],"prefix":"10.1016","volume":"296","author":[{"given":"Chun-Hui","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Pang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2809-4346","authenticated-orcid":false,"given":"Helen H.W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-0675","authenticated-orcid":false,"given":"Wen-Tai","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chou","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.07.010_bib0001","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2026.07.010_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc1092","article-title":"Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma","volume":"3","author":"Hendrix","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.07.010_bib0003","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1126\/science.352.6292.1381","article-title":"Tumors' do-it-yourself blood vessels","volume":"352","author":"Leslie","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.07.010_bib0004","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jcmm.12862","article-title":"Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype","volume":"20","author":"Yao","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2026.07.010_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-018-0920-z","article-title":"The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1","volume":"17","author":"Peng","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2026.07.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013817","article-title":"Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1\/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.trsl.2026.07.010_bib0007","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/ijc.31958","article-title":"The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms","volume":"144","author":"Xia","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2026.07.010_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41417-017-0008-8","article-title":"Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction","volume":"25","author":"Zhang","year":"2018","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.trsl.2026.07.010_bib0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s42003-021-02632-x","article-title":"The development of tumour vascular networks","volume":"4","author":"Fouladzadeh","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.trsl.2026.07.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112791","article-title":"FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy","volume":"42","author":"Cannell","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2026.07.010_bib0011","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1083\/jcb.107.4.1589","article-title":"Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures","volume":"107","author":"Kubota","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2026.07.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.trsl.2026.07.010_bib0013","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.07.010_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-med-051718-013524","article-title":"Precision management of advanced non-small cell lung cancer","volume":"71","author":"Yang","year":"2020","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.trsl.2026.07.010_bib0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1470-2045(19)30035-X","article-title":"Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial","volume":"20","author":"Saito","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2026.07.010_bib0016","article-title":"RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe\/United States subset analysis","volume":"27","author":"Ponce Aix","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.trsl.2026.07.010_bib0017","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamaoncol.2020.1260","article-title":"Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: a phase 1\/2 single-group open-label trial","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.trsl.2026.07.010_bib0018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10456-016-9500-2","article-title":"Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis","volume":"19","author":"Yang","year":"2016","journal-title":"Angiogenesis"},{"key":"10.1016\/j.trsl.2026.07.010_bib0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12885-021-07863-z","article-title":"Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status","volume":"21","author":"He","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trsl.2026.07.010_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2016.01.006","article-title":"Tumor cell vascular mimicry: novel targeting opportunity in melanoma","volume":"159","author":"Hendrix","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2026.07.010_bib0021","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2147\/CMAR.S164675","article-title":"Overview of advances in vasculogenic mimicry - a potential target for tumor therapy","volume":"10","author":"Ge","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.trsl.2026.07.010_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1611038","article-title":"CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1","volume":"29","author":"Shen","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.trsl.2026.07.010_bib0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2016.01.006","article-title":"Tumor cell vascular mimicry: novel targeting opportunity in melanoma","volume":"159","author":"Hendrix","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2026.07.010_bib0024","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41592-020-01027-w","article-title":"Single-objective light sheet microscopy","volume":"18","author":"Strack","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.trsl.2026.07.010_bib0025","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1038\/s41467-024-48010-z","article-title":"A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy","volume":"15","author":"Ascheid","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.07.010_bib0026","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41467-017-01556-7","article-title":"3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry","volume":"8","author":"Velez","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.07.010_bib0027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2026.07.010_bib0028","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.trsl.2026.07.010_bib0029","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-020-0167-1","article-title":"Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2026.07.010_bib0030","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1038\/s41598-017-07622-w","article-title":"Structural and functional identification of vasculogenic mimicry in vitro","volume":"7","author":"Racordon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.07.010_bib0031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jphs.2022.07.001","article-title":"PP2A regulates metastasis and vasculogenic mimicry formation via PI3K\/AKT\/ZEB1 axis in non-small cell lung cancers","volume":"150","author":"Zhang","year":"2022","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.trsl.2026.07.010_bib0032","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41419-021-03682-z","article-title":"HIF-1alpha promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment","volume":"12","author":"Fu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2026.07.010_bib0033","article-title":"Roles of PI3K\/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1alpha, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2026.07.010_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813770","article-title":"The inhibition of the FGFR\/PI3K\/Akt axis by AZD4547 disrupts the proangiogenic microenvironment and vasculogenic mimicry arising from the interplay between endothelial and triple-negative breast cancer cells","volume":"24","author":"Morales-Guadarrama","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.07.010_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112904","article-title":"Inhibition of vasculogenic mimicry and angiogenesis by an anti-EGFR IgG1-human endostatin-P125A fusion protein reduces triple negative breast cancer metastases","volume":"10","author":"Shin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2026.07.010_bib0036","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-021-03716-6","article-title":"HIF1alpha-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia","volume":"12","author":"Laquatra","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2026.07.010_bib0037","article-title":"The mitochondrial chaperone TRAP1 as a candidate target of oncotherapy","volume":"10","author":"Xie","year":"2020","journal-title":"Front Oncol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442600160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442600160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:30:42Z","timestamp":1788017442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152442600160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S193152442600160X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.07.010","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic 3D imaging system detects vasculogenic mimicry and screens inhibitors in EGFR-mutant lung cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}